
The Series C was co-led by Greenoaks and Sequoia Capital, with Alphabet among the investors, the startup said.
Isomorphic Labs has raised $5 billion in a Series C round to support its AI-driven drug discovery work, the startup said Tuesday.
Greenoaks and Sequoia Capital co-led the financing, alongside Andreessen Horowitz. Alphabet, Google’s parent company, also invested.
The company is developing AI tools to design medicines and plans to advance its first therapeutic programs toward clinical trials. Drug discovery startups raised a record $23.2 billion in 2026, according to Dealroom.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.